This study aims to investigate subclinical cardiotoxicity in patients undergoing chemotherapy after breast cancer surgery using cardiac magnetic resonance imaging.
Conducted as a randomized trial involving postoperative breast cancer patients receiving chemotherapy.
Utilized cardiac magnetic resonance imaging for assessment of cardiac health following treatment.
Detected subclinical cardiotoxicity in a significant number of patients via imaging techniques.
Demonstrated that cardiac magnetic resonance imaging can effectively identify early signs of heart damage post-chemotherapy.